Mouse models of focal arterial and venous thrombosis

Basic Research in Cardiology

Volumn 95, Issue 6, 2000, Pages 503-509

  Dorffler Melly J ^a   Schwarte, L A ^a   Ince, C ^a   Levi, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arterial; Murine model; Thromboembolism; Thrombosis; Transgene; Venous

Indexed keywords

ANIMAL MODEL; ARTERY THROMBOSIS; CONFERENCE PAPER; DISEASE MODEL; EXPERIMENTAL MODEL; INJURY; MICROVASCULATURE; MOUSE; NONHUMAN; RECANALIZATION; THROMBOEMBOLISM; THROMBUS; TRANSGENE; TRANSGENIC MOUSE; VEIN THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; THROMBOSIS; VENOUS THROMBOSIS;

EID: 0034530355     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950070028     Document Type: Conference Paper

References (71)

1. Comparison of the antithrombotic effects of FK633, GPIIb/IIIa antagonist, and aspirin in a guinea pig thrombosis model
2. Experimental studies on venous thrombosis: Effect of coagulants, procoagulants and vessel contusion
3. Models to study thrombotic disorders
4. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy
5. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins
6. Thromboembolism and antithrombotic therapy in peripheral arterial disease
7. The effect of thrombin inhibition in a rat arterial thrombosis model
8. Antithrombotic activity of a novel c-terminal hirudin analog in experimental animals
9. The new mouse genetics: Altering the genome by gene targeting
10. Physiological consequences of loss of plasminogen activator gene function in mice
11. A model for arterial neointima formation using perivascular electric injury in mice
12. Vascular wound healing and neointima formation induced by perivascular electric injury in mice
13. Altered vascular injury responses in mice dificient in protease-activatedreceptor-1
14. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation
15. A murine model of myocardial microvascular thrombosis
16. Cerebral protection in homocygous null ICAM-1 mice after middle cerebral artery occlusion
17. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
18. Insights from von Willebrand disease animal models
19. Photochemically induced cortical infarction in the rat
20. Photochemically induced cerebral infarction
21. Ultrastructural analysis of photochemically induced thrombotic stroke in rat brain
22. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
23. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
24. Vitronectin inhibits the thrombotic response to arterial injury in mice
25. Organization of experimental thrombi in arteries and veins. A comparative study
26. Ultrastructural observations of an electro-dense amorphous layer on selectively damaged endothelial cells, a possible trigger of thrombogenesis in vivo, and its inhibition by nafazatrom
27. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
28. Experimental models for the investigation of brain ischemia
29. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine
30. Increased platelet sensitivity to ADP in mice lacking platelet-type 12 lipoxygenase
31. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: Analysis and recommendations
32. A reproducible model of thromboembolic stroke in mice
33. Milrinone, a phosphodiesterase inhibitor, suppresses intimal thickening after photochemically induced endothelial injury in the mouse femoral artery
34. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice
35. Rat model of arterial thrombosis induced by ferric chloride
36. Inducible gene targeting in mice
37. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis
38. Usefulness and limitations of animal models of venous thrombosis
39. Myocardial ischemia and reperfusion: A murine model
40. GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of the hamster
41. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury
42. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model
43. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
44. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice
45. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity
46. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13
47. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice
48. Antiphospholipid antibodies in an in vivo thrombosis model in mice
49. Warner-Lambert Parke Davis Award Lecture: Cytokine-mediated activation of vascular endothelium
50. Conditional gene targeting
51. Chromosome engineering in mice
52. A new model for quantitative in vivo microscopic analysis of thrombus formation and vascular recanalisation: The ear of the hairless (hr/hr) mouse
53. In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization
54. Thrombomodulin gene disruption and mutation in mice
55. Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery
56. Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the rat
57. Hemodynamic at stenoses formed by growing platelet thrombi in mesenteric microvasculature of rat
58. Nonatheromatous arterial thrombosis
59. Of mice and men - The future of cardiovascular research in the molecular era
60. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice
61. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice
62. Epidemiology of venous thromboembolism
63. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis
64. Animal models in the study of myocardial ischaemia and ischaemic syndromes
65. Induction of reproducible brain infarction by photochemically initiated thrombosis
66. Argon laser-induced arterial photothrombosis: Characterization and possible application to therapy of arteriovenous malformations
67. Photochemically induced spinal cord injury in the rat
68. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state
69. Studies in intravascular coagulation: Coagulation changes in isolated venous segments
70. A mouse model of embolic focal cerebral ischemia
71. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance